Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Tuesday, November 3, 2009

Boston Scientific stent gets European approval

By Chris Newmarker

Boston Scientific Corp. on Monday said European regulators have approved its Promus Element stent — the latest version of the company’s drug-coated stent technology meant to prop open previously clogged arteries.

The new Promus Element stents replace the current stents, which were made under an agreement that Boston Scientific (NYSE: BSX) has with Abbott Laboratories (NYSE: ABT). That agreement is set to expire soon.

Natick-based Boston Scientific will begin marketing the Promus Element system immediately in the European Union. The company says the Promus Element includes innovations including a proprietary platinum chromium alloy that has greater strength and flexibility than older alloys.
 

 

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Comments

Please Login/Register to post comments.

No comments have been added or approved.

On the MHT blog now

Bill Gates, Ray Ozzie, Microsoft execs patent 'personal data mining'

By Todd Bishop TechFlash Bill Gates, Ray Ozzie and a bunch of other heavy-hitters from Microsoft are named as inventors on a newly issued patent for a "personal data mining" system that would analyze information and make recommendations with the goal of aiding a person's decisions and improving quality of life. The patent was issued this week, based on a September 2006 patent application. I...

Read More

Boston University - MS MBA
Most Popular Stories
EmailedViewed
Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
FinanceFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of, registration on, this site constitutes acceptance of our User Agreement. Please read our Privacy Policy (updated) A publishing partner with Portfolio